# Orient Pharma Co., Ltd. Yunlin Plant – FDA Inspection, Jul 6, 2018

Source: https://www.keypedia.com/records/fda_inspections/orient-pharma-co-ltd-yunlin-plant/67b73ca1-769c-4cc8-b767-a5b6b3ce38bb
Source feed: FDA_Inspections

> FDA inspection 1062312 of Orient Pharma Co., Ltd. Yunlin Plant, July 06, 2018. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1062312
- Company Name: Orient Pharma Co., Ltd. Yunlin Plant
- Inspection Date: 2018-07-06
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 0

## Related Documents

- FDA Inspection 1274326 - 2025-05-23
- [FDA Inspection 1077757 - 2018-11-16](https://www.keypedia.com/records/fda_inspections/orient-pharma-co-ltd-yunlin-plant/e457d267-6392-48cb-a24b-4e722690553b)
- FDA Inspection 921908 - 2015-04-03
- FDA Inspection 813081 - 2012-12-14

## Related Officers

- [Company Rep](https://www.keypedia.com/people/lindsey-s-fleischman/19ba1e93-b804-487c-8c34-68dc703b0013)

Company: https://www.keypedia.com/companies/orient-pharma-co-ltd-yunlin-plant/c8cecdbc-ad8f-4820-87c2-1c2d47b95e8d

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8